Chang, Lu
Fang, Wenzhuo
Chen, Bin
Cao, Shilei
Fu, Qiang
Zhang, Kaile
Funding for this research was provided by:
the Interdisciplinary Program of Shanghai Jiao Tong University (YG2022ZD020,YG2017QN15,YG2021QN102)
the 2022 Shanghai Leading Talent Training Program (026)
National Scientific Foundation of China (82170694, 81700590, 82370684 and 82470714, 82170694, 81700590, 82370684 and 82470714)
The Natural Science Foundation of Shanghai (20ZR1442100)
Shanghai health committee (20184Y0053)
Jiangsu Key R&D Plan (BE2017664)
Shanghai 2022 “Science and Technology Innovation Action Plan” Medical Innovation Research Program (22Y11905000)
Article History
Received: 20 December 2024
Accepted: 28 April 2025
First Online: 14 May 2025
Declarations
:
: This study was approved by and the Ethics Committee of Shanghai Sixth People’s Hospital, Shanghai, China(2023-019-(1); 24 th March 2023). All methods were carried out in accordance with relevant guidelines and regulation. Verbal and written informed consent was obtained from of all subjects and/or their legal guardian(s). This clinical trial is registered on the WHO International Clinical Trial Registry Platform. Registration Date (13/09/2024). Registration Number (ChiCTR2400089727).
: The authors declare no competing interests.
: Our study complies with the CONSORT guidelines.